Clinical Trial Detail

NCT ID NCT02122809
Title Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Chipscreen Biosciences, Ltd.
Indications

Advanced Solid Tumor

ovarian cancer

renal cell carcinoma

gastrointestinal stromal tumor

non-small cell lung carcinoma

stomach cancer

colorectal cancer

Therapies

Chiauranib

Age Groups: adult

No variant requirements are available.